Rui Pei

Atezolizumab compared to chemotherapy for first-line treatment in non-small cell lung cancer with high PD-L1 expression: a cost-effectiveness analysis from US and Chinese perspectives

Shao Liu, Shuqiao Cheng, Lanhua Tang, 2021, Annals of translational medicine.

Osimertinib versus platinum-pemetrexed in patients with previously treated EGFR T790M advanced non-small cell lung cancer: An updated AURA3 trial-based cost-effectiveness analysis

Yin Shi, Rui Pei, Shao-Xing Liu, 2022, Frontiers in Oncology.

Nivolumab vs Pembrolizumab for Treatment of US Patients With Platinum-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Shuhe Lv, Shao Liu, Yin Shi, 2021, JAMA network open.

Rhein Derivatives, A Promising Pivot?

G. Lei, Shao Liu, Yueping Jiang, 2020, Mini reviews in medicinal chemistry.